ErbB2/Her2 抗体
Quick Overview for ErbB2/Her2 抗体 (ABIN2473977)
抗原
See all ErbB2/Her2 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
产品特性
- Purified IgG
-
纯化方法
- Purified
-
亚型
- IgG2a
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1.0 mg/mL
-
-
-
: "Potentiation of paclitaxel activity by the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin in human ovarian carcinoma cell lines with high levels of activated AKT." in: Molecular cancer therapeutics, Vol. 5, Issue 5, pp. 1197-208, (2006) (PubMed).
-
: "Potentiation of paclitaxel activity by the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin in human ovarian carcinoma cell lines with high levels of activated AKT." in: Molecular cancer therapeutics, Vol. 5, Issue 5, pp. 1197-208, (2006) (PubMed).
-
- ErbB2/Her2 (Receptor tyrosine-protein kinase erbB-2 (ErbB2/Her2))
-
别名
- HER2/neu
-
背景
- Synonyms: CD340
-
基因ID
- 2064
-
UniProt
- P04626
-
途径
- RTK signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Skeletal Muscle Fiber Development
抗原
-